Endovascular Engineering ENGULF Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Klein, MD
Piedmont Heart
Principal Investigator - Julie Bulman, MD
Beth Israel Deaconess Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pih Health Good Samaritan Hospital
Los Angeles, California, United States
- Huntington Hospital
Pasadena, California, United States
- the Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
Torrance, California, United States
- Torrance Memorial Medical Center
Torrance, California, United States
- Delray Medical Center
Delray Beach, Florida, United States
- Baptist Health Research Institute
Jacksonville, Florida, United States
- Hca Florida Memorial Hospital
Jacksonville, Florida, United States
- Northside Hospital
Atlanta, Georgia, United States
- Piedmont Heart
Atlanta, Georgia, United States
- Indiana University
Indianapolis, Indiana, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Trihealth Hatton Research Institute
Cincinnati, Ohio, United States
- Temple University
Philadelphia, Pennsylvania, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Wellmont Cardiology Services / Ballad Health
Kingsport, Tennessee, United States
- Tennova Healthcare - Turkey Creek Medical Center
Knoxville, Tennessee, United States
- Austin Heart
Austin, Texas, United States
- Baylor Scott & White Research Institute
Dallas, Texas, United States
- Ut Health
Houston, Texas, United States
- Gundersen Health
La Crosse, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Jan 2023
- Primary completion
- 2 Mar 2026
- Completion
- 30 Mar 2026
- Last update posted
- 14 Apr 2026
- Registered enrollment
- 177
- Registry id
- NCT05597891
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.